Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul-Aug;37(4):108-10.
doi: 10.1097/WNF.0000000000000039.

Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders

Kazuhiko Iwahashi  1 , Daisuke Nishizawa, Shin Narita, Maki Numajiri, Ohoshi Murayama, Eiji Yoshihara, Yuuya Onozawa, Kenta Nagahori, Fumihiko Fukamauchi, Kazutaka Ikeda, Jun Ishigooka
Affiliations
Free PMC article

Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders

Kazuhiko Iwahashi et al. Clin Neuropharmacol. 2014 Jul-Aug.
Free PMC article

Abstract

The GSK-3β gene, GSK3B, codes for an enzyme that is a target for the action of mood stabilizers, lithium and possibly valproic acid.In this study, the relationship between haplotypes consisting of single nucleotide polymorphisms (SNPs) of GSK3B -50T/C and -1727A/T and the effect of lithium was studied among Japanese bipolar disorder lithium nonresponders and responders.The distributions of the GSK3B haplotypes (-50T/C and -1727A/T) showed a trend for significant difference between the lithium nonresponders and responders (global P=0.07074). Haplotype 1 (T-A) was associated with a higher lithium response (haplotype-specific P=0.03477), whereas haplotype 2 (C-A) was associated with a lower lithium response (haplotype-specific P=0.03443).The pairwise D' and r values between the 2 SNPs in this study were 1.0 and 0.097, respectively. The 2 SNPs showed weak linkage disequilibrium with each other.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
SNPs in the promoter region of the GSK-3β gene. Regulatory cis- elements for transcription are indicated according to the report of Lau et al (1999).
See this image and copyright information in PMC

References

    1. Gould TD, Manji HK. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 2005; 30: 1223– 1237 - PubMed
    1. Saus E, Soria V, Escaramís G, et al. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression. Genes Brain Behav 2010; 9: 799– 807 - PubMed
    1. Shaw PC, Davies AF, Lau KF, et al. Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes. Genome 1998; 41: 720– 727 - PubMed
    1. Bailer U, Leisch F, Meszaros K, et al. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry 2002; 52: 40– 52 - PubMed
    1. Russ C, Lovestone S, Powell JF. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer’s disease. Mol Psychiatry 2001; 6: 320– 324 - PubMed

Publication types